BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24587645)

  • 21. Research progress on the immune microenvironment and immunotherapy in gastric cancer.
    Mou P; Ge QH; Sheng R; Zhu TF; Liu Y; Ding K
    Front Immunol; 2023; 14():1291117. PubMed ID: 38077373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
    Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
    Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy for colorectal cancer.
    Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of cancer immunotherapeutic strategies.
    Wahid B; Ali A; Rafique S; Waqar M; Wasim M; Wahid K; Idrees M
    Immunotherapy; 2018 Aug; 10(11):999-1010. PubMed ID: 30149763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged overall survival in gastric cancer patients after adoptive immunotherapy.
    Zhang GQ; Zhao H; Wu JY; Li JY; Yan X; Wang G; Wu LL; Zhang XG; Shao Y; Wang Y; Jiao SC
    World J Gastroenterol; 2015 Mar; 21(9):2777-85. PubMed ID: 25759549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging trends in the immunotherapy of pancreatic cancer.
    Banerjee K; Kumar S; Ross KA; Gautam S; Poelaert B; Nasser MW; Aithal A; Bhatia R; Wannemuehler MJ; Narasimhan B; Solheim JC; Batra SK; Jain M
    Cancer Lett; 2018 Mar; 417():35-46. PubMed ID: 29242097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines.
    Patel A; Fong L
    Oncology (Williston Park); 2018 Mar; 32(3):112-20. PubMed ID: 29548065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy for gastrointestinal malignancies.
    Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA
    Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of therapeutic approaches to gastric cancer.
    Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
    J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity and immune suppression in human ovarian cancer.
    Preston CC; Goode EL; Hartmann LC; Kalli KR; Knutson KL
    Immunotherapy; 2011 Apr; 3(4):539-56. PubMed ID: 21463194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer immunotherapy: moving forward with peptide T cell vaccines.
    Kumai T; Fan A; Harabuchi Y; Celis E
    Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer.
    Bauer C; Kühnemuth B; Duewell P; Ormanns S; Gress T; Schnurr M
    Cancer Lett; 2016 Oct; 381(1):259-68. PubMed ID: 26968250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy in human colorectal cancer: Challenges and prospective.
    Sun X; Suo J; Yan J
    World J Gastroenterol; 2016 Jul; 22(28):6362-72. PubMed ID: 27605872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
    Blair AB; Murphy A
    Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy in Ovarian Cancer.
    Wang W; Liu JR; Zou W
    Surg Oncol Clin N Am; 2019 Jul; 28(3):447-464. PubMed ID: 31079799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer.
    Vrána D; Matzenauer M; Neoral Č; Aujeský R; Vrba R; Melichar B; Rušarová N; Bartoušková M; Jankowski J
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunology and immunotherapy in gastric cancer.
    Xu X; Chen J; Li W; Feng C; Liu Q; Gao W; He M
    Clin Exp Med; 2023 Nov; 23(7):3189-3204. PubMed ID: 37322134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.